By 8-12 weeks , the full benefits of treatment should become evident: substantial visceral fat reduction, better body composition, and enhanced cognitive function
Serotonin Syndrome Counteraction A 2005 study in the European Journal of Pharmacology (PMID: 15840402) induced severe serotonin syndrome using pargyline (MAO inhibitor) plus L-tryptophan (serotonin precursor), producing forepaw treading, hindlimb abduction, wet dog shake, and hyperthermia mediated primarily through 5-HT2A receptors
The formulation is produced exclusively for research use and is supplied with documentation supporting laboratory quality requirements
A consultation will help determine whether this treatment is suitable for you, although testing can be arranged if needed
While originally studied in injectable form, advancements in peptide science have led to the development of oral versions that seek to provide similar benefits through daily supplementation